orBec
Showing 1 - 6 of 6
Chronic Gastrointestinal GVHD Trial in Hackensack, Buffalo, Nashville (orBec, Placebo)
Terminated
- Chronic Gastrointestinal Graft vs Host Disease
- orBec
- Placebo
-
Hackensack, New Jersey
- +2 more
Oct 3, 2018
Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, Sulfonylurea, Metformin)
Completed
- Diabetes Mellitus, Type 2
- Rosiglitazone
- +2 more
-
Miranda, New South Wales, Australia
- +446 more
Mar 21, 2017
Acute Gastrointestinal GVHD Trial in Buffalo, Durham, Seattle (oral beclomethasone 17,21-dipropionate, Placebo)
Terminated
- Acute Gastrointestinal Graft vs Host Disease
- oral beclomethasone 17,21-dipropionate
- Placebo
-
Buffalo, New York
- +2 more
Oct 10, 2013
Evaluation of Target Organs Damage in Hypertensive Patients
Completed
- Target Organs Damage
- +3 more
-
Abbaretz, France
- +907 more
May 11, 2011
Hypertension in General Practitioner (GP) Consultation
Completed
- Hypertension
-
Ablon Sur Seine, France
- +1386 more
Aug 4, 2009
Graft Vs Host Disease, Gastrointestinal GVHD Trial in Seattle (Oral beclomethasone dipropionate (drug))
Completed
- Graft Vs Host Disease
- Gastrointestinal Graft-Versus-Host Disease
- Oral beclomethasone dipropionate (drug)
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Oct 4, 2005